Literature DB >> 20658476

Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains.

Ivan Aprahamian1, Breno Satler Diniz, Rafael Izbicki, Márcia Radanovic, Paula Villela Nunes, Orestes Vicente Forlenza.   

Abstract

OBJECTIVE: To identify the CAMCOG sub-items that best contribute for the identification of patients with mild cognitive impairment (MCI) and incipient Alzheimer's disease (AD) in clinical practice.
METHODS: Cross-sectional assessment of 272 older adults (98 MCI, 82 AD, and 92 controls) with a standardized neuropsychological battery and the CAMCOG schedule. Backward logistic regression analysis with diagnosis (MCI and controls) as dependent variable and the sub-items of the CAMCOG as independent variable was carried out to determine the CAMCOG sub-items that predicted the diagnosis of MCI.
RESULTS: Lower scores on Language, Memory, Praxis, and Calculation CAMCOG sub-items were significantly associated with the diagnosis of MCI. A composite score obtained by the sum of these scores significantly discriminated MCI patients from comparison groups. This reduced version of the CAMCOG showed similar diagnostic accuracy than the original schedule for the identification of patients with MCI as compared to controls (AUC = 0.80 ± 0.03 for the reduced CAMCOG; AUC = 0.79 ± 0.03 for the original CAMCOG).
CONCLUSION: This reduced version of the CAMCOG had similar diagnostic properties as the original CAMCOG and was faster and easier to administer, rendering it more suitable for the screening of subtle cognitive deficits in general clinical practice.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20658476     DOI: 10.1002/gps.2540

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

1.  Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores.

Authors:  Marialuisa Restaino; Fiona E Matthews; Thais Minett; Emiliano Albanese; Carol Brayne; Blossom Christa Maree Stephan
Journal:  Age Ageing       Date:  2013-07-19       Impact factor: 10.668

2.  Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.

Authors:  Eric D Hamlett; Edward J Goetzl; Aurélie Ledreux; Vitaly Vasilevko; Heather A Boger; Angela LaRosa; David Clark; Steven L Carroll; María Carmona-Iragui; Juan Fortea; Elliott J Mufson; Marwan Sabbagh; Abdul H Mohammed; Dean Hartley; Eric Doran; Ira T Lott; Ann-Charlotte Granholm
Journal:  Alzheimers Dement       Date:  2016-10-15       Impact factor: 21.566

Review 3.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

Review 4.  Brief Cognitive Tests in the Case of Dementia and Alzheimer's Disease Early Diagnosis.

Authors:  Maria Sagiadinou; Antonia Plerou
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Clinical applicability and cutoff values for an unstructured neuropsychological assessment protocol for older adults with low formal education.

Authors:  Jonas Jardim de Paula; Laiss Bertola; Rafaela Teixeira Ávila; Lafaiete Moreira; Gabriel Coutinho; Edgar Nunes de Moraes; Maria Aparecida Camargos Bicalho; Rodrigo Nicolato; Breno Satler Diniz; Leandro Fernandes Malloy-Diniz
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 6.  Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions.

Authors:  Mengxi Yang; Di Sun; Yu Wang; Mengwen Yan; Jingang Zheng; Jingyi Ren
Journal:  Front Cardiovasc Med       Date:  2022-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.